NCT06136039 Effect of Sarcopenia on Clinical Outcome of Total Knee Arthroplasty
| NCT ID | NCT06136039 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Gangnam Severance Hospital |
| Condition | Knee Osteoarthritis |
| Study Type | INTERVENTIONAL |
| Enrollment | 150 participants |
| Start Date | 2022-06-03 |
| Primary Completion | 2024-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 150 participants in total. It began in 2022-06-03 with a primary completion date of 2024-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
As human life expectancy increases, the prevalence of degenerative osteoarthritis of the knee joints is steadily rising, leading to a significant surge in the frequency of total knee arthroplasty (TKA). However, research on sarcopenia in the population that comprises the primary recipients of these orthopedic joint surgeries has been notably lacking. Since the release of the 2019 Consensus update on sarcopenia by the Asian Walking Group for Sarcopenia (AWGS) in 2020, research on sarcopenia has gained momentum in various domains. Yet, as previously mentioned, the field of orthopedics still lags behind in investigating sarcopenia. Therefore, it is believed that establishing the relationship between sarcopenia and surgical outcomes in the elderly, who are the primary targets of orthopedic joint replacement surgery, could offer insights to further enhance the results of joint replacement surgeries.
Eligibility Criteria
Inclusion Criteria: * A woman aged 60 or older who is undergoing TKA due to degenerative osteoarthritis of the knee joint at the our institution. Exclusion Criteria: 1. Male 2. Under 60 years of age 3. Patients with a history of rheumatoid arthritis, traumatic joint disease, and post-infection joint disease 4. Patients who cannot undergo tests for muscle weakness diagnosis A. Patients unable to walk B. Patients unable to stand alone due to conditions like cerebral palsy or brain disorders C. Patients unable to use muscle strength 5. Patients considered inappropriate for recruitment in this study based on the judgment of the research team.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06136039 clinical trial?
This trial is open to female participants only, aged 60 Years or older, studying Knee Osteoarthritis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06136039 currently recruiting?
Yes, NCT06136039 is actively recruiting participants. Contact the research team at gsirb@yuhs.ac for enrollment information.
Where is the NCT06136039 trial being conducted?
This trial is being conducted at Seoul, South Korea.
Who is sponsoring the NCT06136039 clinical trial?
NCT06136039 is sponsored by Gangnam Severance Hospital. The trial plans to enroll 150 participants.